Literature DB >> 4301034

[Chemotherapeutic studies on advanced tuberculosis in mice].

F Grumbach.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 4301034

Source DB:  PubMed          Journal:  Bibl Tuberc        ISSN: 0300-1121


× No keyword cloud information.
  5 in total

1.  [Contribution to the problem of resistance stability of the so-called polyresistant mycobacteria from patients with widespread chronic pulmonary tuberculosis].

Authors:  J Tousek; L Trnka; A Havel
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1968

2.  Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice?

Authors:  N Lounis; B Ji; C Truffot-Pernot; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

3.  Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice.

Authors:  Ming Zhang; Si-Yang Li; Ian M Rosenthal; Deepak V Almeida; Zahoor Ahmad; Paul J Converse; Charles A Peloquin; Eric L Nuermberger; Jacques H Grosset
Journal:  Am J Respir Crit Care Med       Date:  2011-02-17       Impact factor: 21.405

4.  Gatifloxacin and ethionamide as the foundation for therapy of tuberculosis.

Authors:  Michael H Cynamon; Mary Sklaney
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

5.  Sterilizing activity of second-line regimens containing TMC207 in a murine model of tuberculosis.

Authors:  Nicolas Veziris; Murad Ibrahim; Nacer Lounis; Koen Andries; Vincent Jarlier
Journal:  PLoS One       Date:  2011-03-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.